Imagen de Portada

Augmented drug resistance of osteosarcoma cells within decalcified bone matrix scaffold: The role of glutamine metabolism

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Jiaxin Ren, Cheng Zhao, Ruizhu Sun, Jian Sun, Laiya Lu, Jun Wu, Shuaijun Li, Lei Cui
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	International Journal of Cancer
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The role of programmed cell death in osteosarcoma: From pathogenesis to therapy
por: Suqing Liu, et al.
Publicado: (2024)

Extracellular matrix production and oxygen diffusion regulate chemotherapeutic response in osteosarcoma spheroids
por: Isabel S. Sagheb, et al.
Publicado: (2024)

The role of cytokines in ovarian cancer drug resistance
por: Lu Wang, et al.
Publicado: (2025)

FoxG1/BNIP3 axis promotes mitophagy and blunts cisplatin resistance in osteosarcoma
por: Baolong Pan, et al.
Publicado: (2024)

Consensus recommendations in the management of jaw (gnathic) osteosarcoma
por: Matthew S. Dietz, et al.
Publicado: (2026)

Concerning trends and potential issues in osteosarcoma research publication
por: Keisuke Horiuchi, et al.
Publicado: (2024)

Single‐cell landscape reveals the immune heterogeneity of bone marrow involvement in peripheral T‐cell lymphoma
por: Jun Liu, et al.
Publicado: (2024)

Li–Fraumeni‐associated osteosarcomas: The French experience
por: Emilie Saucier, et al.
Publicado: (2024)

Contemporary surgical management of osteosarcoma and Ewing sarcoma
por: Alexandra K. Callan, et al.
Publicado: (2024)

Osteosarcoma is not a single disease: Considerations for multidisciplinary management of jaw (gnathic) osteosarcoma
por: Damon R. Reed, et al.
Publicado: (2026)

Emerging role of antibody–drug conjugates in gastrointestinal malignancies
por: Uqba Khan, et al.
Publicado: (2026)

Identifying the predictive role and the related drugs of oxidative stress genes in the hepatocellular carcinoma
por: Guole Nie, et al.
Publicado: (2024)

MYC amplification and MYC protein expression are poor prognostic markers in pediatric and young adult osteosarcoma
por: Matthew R. Nagy, et al.
Publicado: (2025)

The lung pre‐metastatic niche in osteosarcoma: Mechanism and therapeutic intervention
por: Daqing Wang, et al.
Publicado: (2025)

Bone marrow hematoidin crystals in a pediatric patient with chondroblastic osteosarcoma
por: Yun Zhang, et al.
Publicado: (2024)

Prognostic value of hemogram parameters in osteosarcoma: The French OS2006 experience
por: Paul Bastard, et al.
Publicado: (2024)

MGMT protein expression is a reliable predictive biomarker for temozolomide‐containing chemotherapy in osteosarcoma
por: Yoshinori Uchihara, et al.
Publicado: (2024)

Myc upregulates Ggct, γ‐glutamylcyclotransferase to promote development of p53‐deficient osteosarcoma
por: Tomoya Ueno, et al.
Publicado: (2024)

Comments on “CTHRC1 promotes bone metastasis in prostate cancer”
por: Yongzheng Han, et al.
Publicado: (2025)

Targeting erythroid progenitor cells for cancer immunotherapy
por: Su‐Ran Li, et al.
Publicado: (2024)

Multifaceted roles and functions of SOX30 in human cancer
por: Na Sun, et al.
Publicado: (2024)

High‐quality expert annotations enhance artificial intelligence model accuracy for osteosarcoma X‐ray diagnosis
por: Joe Hasei, et al.
Publicado: (2024)

The efficacy of gemcitabine and docetaxel chemotherapy for the treatment of relapsed and refractory osteosarcoma: A systematic review and pre‐clinical study
por: Kaan Low, et al.
Publicado: (2024)

Efficacy of first‐line treatment options beyond RET‐TKIs in advanced RET‐rearranged non‐small cell lung cancer: A multi‐center real‐world study
por: Yihui Ge, et al.
Publicado: (2024)

New players in the landscape of renal cell carcinoma bone metastasis and therapeutic opportunities
por: Beatrice Cesana, et al.
Publicado: (2024)

The effect of self‐designed metabolic equivalent exercises on cancer‐related fatigue in patients with gastric cancer: A randomized controlled trial
por: Xiao Xin, et al.
Publicado: (2024)

Persist or resist: Immune checkpoint inhibitors in EGFR‐mutated NSCLC
por: Pengcheng Zhu, et al.
Publicado: (2024)

Nomogram predicts survival and surgical benefits for patients with breast cancer with initial bone metastasis: A population‐based study
por: Xingtong Zhou, et al.
Publicado: (2024)

Spheroid culture to select theoretical therapeutic drugs in intravascular large B‐cell lymphoma
por: Mika Takai, et al.
Publicado: (2024)

Sex‐based immune microenvironmental feature heterogeneity in response to PD ‐1 blockade in combination with chemotherapy for patients with untreated advanced non‐small‐cell lung cancer
por: Xiaofeng Yu, et al.
Publicado: (2024)

Mapping the antibody–drug‐conjugates landscape in non–small cell lung cancer: Where are we and where are we going?
por: Claudia Parisi, et al.
Publicado: (2026)

Network‐based identification of key proteins and repositioning of drugs for non‐small cell lung cancer
por: Oluwatosin Maryam Adeyemo, et al.
Publicado: (2024)

Long‐term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS)
por: Kerri Becktell, et al.
Publicado: (2024)

Optimizing treatment for platinum‐resistant ovarian clear cell carcinoma: Efficacy of gemcitabine and combination therapy with bevacizumab
por: Yasunori Yoshino, et al.
Publicado: (2025)

Enhancing the role of social work in managing cancer risks among LGBTQ+ populations
por: Cheng Liu
Publicado: (2024)

Hypoxia-inducible factor HIF-1α modulates drugs resistance in colon cancer cells
por: Martha Leonor Pinzon-Daza
Publicado: (2018)

Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade–resistant melanoma: Final analysis from a phase 1b study
por: Mohammed M. Milhem, et al.
Publicado: (2025)

The protective role of anti‐parkinsonian drugs in pancreatic cancer risk: A comprehensive case–control study in Taiwan
por: Hsuan‐Chia Yang, et al.
Publicado: (2024)

Hematopoietic stem cell transplantation in two sisters with bone marrow failure associated with POLE gene variants
por: Kentaro Fujimori, et al.
Publicado: (2024)

Role of immune checkpoint inhibitors combined with chemotherapy in recurrent drug‐resistant gestational trophoblastic neoplasia: Four case reports and literature review
por: Weiqing Liu, et al.
Publicado: (2024)